Efficacy and safety of hepatitis A vaccination in kidney transplant recipients

@article{Jeon2014EfficacyAS,
  title={Efficacy and safety of hepatitis A vaccination in kidney transplant recipients},
  author={Hee Jung Jeon and Han Ro and J.C. Jeong and Tai Yeon Koo and M. Han and Sang-il Min and Kook-Hwan Oh and Jongwon Ha and Curie Ahn and J Y Yang},
  journal={Transplant Infectious Disease},
  year={2014},
  volume={16},
  pages={511 - 515}
}
  • H. Jeon, H. Ro, +7 authors J. Yang
  • Published 1 June 2014
  • Medicine, Biology
  • Transplant Infectious Disease
In recent years, symptomatic hepatitis A virus (HAV) infection has been reported with increasing frequency in Korea. Therefore, HAV vaccination should be considered in kidney transplant recipients (KTRs). The study investigated the efficacy and safety of HAV vaccination in KTRs under modern triple immunosuppressive agents. 
View on Wiley
210.101.116.28
34 Citations
Background Citations
6
Results Citations
1

34 Citations

Citation Type

Citation Type

Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients
TLDR
No study has evaluated the serological response to HAV vaccine in allogeneic HSCT recipients, and most HSCT revaccination guidelines advise vaccination as optional, following the country recommendation.
Immunizations in Chronic Kidney Disease and Kidney Transplantation
TLDR
The current data in patients with CKD, on dialysis, and in KT recipients is reviewed to provide further guidance for clinicians regarding vaccine optimization in this patient population.
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
TLDR
Vaccine-preventable infections represent a significant burden of disease in solid-organ transplant (SOT) recipients and are associated with worse outcomes compared with the general population.
Seroprevalence of Hepatitis a in Hemodialysis Patient Candidate for Kidney Transplant Younger Than Forty Years
TLDR
The seroprevalence of hepatitis A in hemodialysis patients less than forty years serving kidney transplant candidates to follow vaccination policy for them is evaluated to show the check of antibodies in patients undergoing kidney transplantation and vaccination in seronegative persons is a logical.
Vaccination of Transplant Recipients
TLDR
This chapter reviews current information and recommendations regarding vaccinations of hematopoietic stem cell and solid organ transplant recipients.
Vaccination and their importance for lung transplant recipients in a COVID-19 world
TLDR
Vaccine design based on mRNA technology could allow the design of an array of vaccines against other respiratory viruses, offering a better protection for lung transplant patients.
Is there a higher risk of a complicated course of hepatitis A in kidney transplant patients?
Viral seroprevalence in pediatric kidney transplant recipients
TLDR
It is important to screen patients with chronic kidney disease in terms of vaccine-preventable diseases to identify risky groups of patients and to immunize these patients before end-stage kidney disease develops, and to evaluate the antibody seroprevalence against viral agents in kidney transplant recipients.
Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies
TLDR
The potentiality of implementing cocoon strategies for the high-risk group of CKD patients is discussed and it is concluded that this not yet officially recommended policy can substantially contribute to protection against infection and motivate vaccination among families and healthcare workers.
Common viral infections in kidney transplant recipients
TLDR
The etiology, diagnosis, prevention, and treatment of viral infections that commonly affect kidney transplant recipients that are used effectively to reduce the incidence of these viral infections are described.
...
1
2
3
4
...

References

SHOWING 1-10 OF 14 REFERENCES
Safety and efficacy of hepatitis A vaccination in liver transplantation recipients.
TLDR
Efficacy of HAV vaccination in OLT recipients, as measured by a commercially available enzyme immunoassay, is low and alternative strategies should be developed to improve response rate.
Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.
TLDR
Hepatitis A vaccine can be recommended to LTX and RTX patients, but the patients should receive a full course of 2 doses before imminent exposure, as the vaccine was well tolerated.
Current status of liver diseases in Korea: hepatitis A.
  • S. Kwon
  • Medicine, Biology
    The Korean journal of hepatology
  • 2009
TLDR
Preventative measures including universal vaccination in infants and active immunization of the adult population should be considered in Korea.
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
  • Gerald DaRoza, A. Loewen, +6 authors A. Levin
  • Medicine
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2003
TLDR
This is the largest study to show in a well-characterized cohort that patients with higher GFR levels are more likely to respond to hepatitis B vaccination programs with seroconversion, independent of other factors.
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
TLDR
Hepatitis A vaccine was well tolerated and induced a satisfactory immune response in patients with chronic hepatitis B, chronic hepatitis C, and miscellaneous CLD.
Immunization in transplantation: review of the recent literature
TLDR
A review of the literature published during the last 15 months, critically summarize vaccine-oriented articles in SOT candidates or recipients finds that lung transplantation, mycophenolate treatment, increasing age and end-stage organ failure were frequently identified as risk factors for nonresponse to immunization.
Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses.
TLDR
The vigorous antibody response and the evidence of cellular immunity support the efficacy of influenza vaccination in patients on alternate-day or low-dose daily steroid therapy.
The Effect of Erythropoietin Therapy and Hemoglobin Levels on the Immune Response to Engerix-B Vaccination in Chronic Kidney Disease
TLDR
Predialytic patients treated with rEPO and with hemoglobin levels higher than 11 gr/dL had significantly better immune response outcomes to Engerix-B vaccination, suggesting immunization against hepatitis B infection should be considered at early stages of CKD prior to the deterioration in kidney functions and the development of renal anemia.
[The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
TLDR
Catch-up vaccination for teenagers and young adults is needed and Immunizing children with HAV vaccine as a routine schedule should be considered.
[The age-specific seroprevalence of hepatitis A virus antibody in Korea].
TLDR
The seroprevalence of hepatitis A virus antibody in Korean population below 40 is quite low and immunity to hepatitis Airus in those subjects can be a public health issue, and a policy for hepatitis A vaccination in population below40 might be warranted.
...
1
2
...